Sonal Singh

Summary

Affiliation: Johns Hopkins University
Country: USA

Publications

  1. ncbi Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    CMAJ 183:1359-66. 2011
  2. ncbi Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Baltimore, MD 21287, USA
    BMJ 342:d3215. 2011
  3. ncbi Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St, Suite 8063, Baltimore, MD 21287, USA
    Thorax 66:383-8. 2011
  4. ncbi An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Int J Chron Obstruct Pulmon Dis 5:189-95. 2010
  5. ncbi Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Curr Opin Pulm Med 16:118-22. 2010
  6. ncbi Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Sonal Singh
    Department of Medicine, One Medical Center Blvd, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    JAMA 300:1439-50. 2008
  7. ncbi The safety of rosiglitazone in the treatment of type 2 diabetes
    Sonal Singh
    Wake Forest University School of Medicine, Department of Medicine, Winston Salem, NC 27103, USA
    Expert Opin Drug Saf 7:579-85. 2008
  8. ncbi Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis
    Sonal Singh
    Department of Medicine, Wake Forest University School of Medicine, One Medical Center Boulevard, Winston Salem, NC 27157, USA
    Arch Intern Med 169:219-29. 2009
  9. ncbi Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis
    Sonal Singh
    Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    JAMA 298:1189-95. 2007
  10. ncbi Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
    Wendy L Bennett
    The Johns Hopkins University School of Medicine and The Johns Hopkins Bloomberg School of Public Health, 2024 East Monument Street, Baltimore, MD 21205, USA
    Ann Intern Med 154:602-13. 2011

Collaborators

Detail Information

Publications11

  1. ncbi Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-analysis
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    CMAJ 183:1359-66. 2011
    ..We conducted a systematic review and meta-analysis of randomized controlled trials to ascertain the serious adverse cardiovascular effects of varenicline compared with placebo among tobacco users...
  2. ncbi Mortality associated with tiotropium mist inhaler in patients with chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled trials
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument Street, Baltimore, MD 21287, USA
    BMJ 342:d3215. 2011
    ..To systematically review the risk of mortality associated with long term use of tiotropium delivered using a mist inhaler for symptomatic improvement in chronic obstructive pulmonary disease...
  3. ncbi Long-term use of thiazolidinediones and the associated risk of pneumonia or lower respiratory tract infection: systematic review and meta-analysis
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, 1830 E Monument St, Suite 8063, Baltimore, MD 21287, USA
    Thorax 66:383-8. 2011
    ..The authors aimed to systematically determine the risk of pneumonia or lower respiratory tract infections associated with thiazolidinediones...
  4. ncbi An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Int J Chron Obstruct Pulmon Dis 5:189-95. 2010
    ..The benefit harm profile of inhaled corticosteroids, and their effect on patient oriented outcomes and comorbid pneumonia, osteoporosis and cardiovascular disease in patients with chronic obstructive pulmonary disease remain uncertain...
  5. ncbi Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: a critical review and update
    Sonal Singh
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Curr Opin Pulm Med 16:118-22. 2010
    ....
  6. ncbi Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis
    Sonal Singh
    Department of Medicine, One Medical Center Blvd, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    JAMA 300:1439-50. 2008
    ..Inhaled anticholinergics (ipratropium bromide or tiotropium bromide) are widely used in patients with chronic obstructive pulmonary disease (COPD) but their effect on the risk of cardiovascular outcomes is unknown...
  7. ncbi The safety of rosiglitazone in the treatment of type 2 diabetes
    Sonal Singh
    Wake Forest University School of Medicine, Department of Medicine, Winston Salem, NC 27103, USA
    Expert Opin Drug Saf 7:579-85. 2008
    ..The thiazolidinediones including rosiglitazone are approved for the treatment of Type 2 diabetes on the basis of their ability to lower blood sugar and surrogate markers of cardiovascular disease...
  8. ncbi Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis
    Sonal Singh
    Department of Medicine, Wake Forest University School of Medicine, One Medical Center Boulevard, Winston Salem, NC 27157, USA
    Arch Intern Med 169:219-29. 2009
    ..We aimed to ascertain the risk of pneumonia with long-term inhaled corticosteroid use among patients with chronic obstructive pulmonary disease (COPD)...
  9. ncbi Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis
    Sonal Singh
    Department of Medicine, Wake Forest University School of Medicine, Winston Salem, NC 27157, USA
    JAMA 298:1189-95. 2007
    ..Recent reports of serious adverse events with rosiglitazone use have raised questions about whether the evidence of harm justifies its use for treatment of type 2 diabetes...
  10. ncbi Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
    Wendy L Bennett
    The Johns Hopkins University School of Medicine and The Johns Hopkins Bloomberg School of Public Health, 2024 East Monument Street, Baltimore, MD 21205, USA
    Ann Intern Med 154:602-13. 2011
    ..Given the increase in medications for type 2 diabetes mellitus, clinicians and patients need information about their effectiveness and safety to make informed choices...
  11. ncbi Network meta-analysis-highly attractive but more methodological research is needed
    Tianjing Li
    Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21212, USA
    BMC Med 9:79. 2011
    ..Since this commentary reflects the discussion at that meeting, it is not intended to provide an overview of the field...